Navigation Links
UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine
Date:5/23/2013

Fort Myers, FL (PRWEB) May 23, 2013

On April 29th, 2013, UV Technologies issued a daring prediction in the midst of growing numbers of H7N9 cases and deaths. The headline read, "UV Technologies, Makers of UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in Northern Hemisphere as Available Daylight Increases.” In fact, as of May 13th no new cases have been reported.

Quoting Kevin McGuire, president of UV Technologies, "The migration of the flu is as predictable as flowers budding in the spring and leaves changing in the fall. The progression of H7N9 should be just as predictable." In fact it was. The press release went on to state, "As China heads into summer, the cases of flu in that country and region will subside and will most likely reappear in the southern hemisphere in places like Australia where available sunlight is about to reach its annual low on June 21. These events will likely occur without the involvement of a vaccine for H7N9 that does not exist at this time."

According to Mr. McGuire, "The seasonality of the flu is well known but until now, no one has adequately explained the reason for it. UV Technologies flu model and groundbreaking UV-Aid technology is based on the ability of the human body to use the energy from the sun's rays to produce hydrogen peroxide which is a known antiviral agent. "

When asked if he thought the culling of chickens and the closing of live poultry markets in China had any impact on the end of new H7N9 cases, Mr. McGuire responded, "While the actions were prudent they do not explain why farmers, vendors, and others still in proximity to these chickens are no longer contracting the flu. UV Technologies model explains this phenomenon."

UV Technologies, LLC has been test marketing UV-Aid for over two years in the US with promising results. UV Technologies has a flawless record with the Better Business Bureau (BBB) since accreditation in February of 2011. UV-Aid has over 5,000 fans on facebook counting many testimonials pointing to the effectiveness of UV-Aid.

UV-Aid technology is based on the process of photo-oxidation, the natural response of the human body to daylight. The light emitted by the UV-Aid is shined into the nose, mouth, and ear cavities to stimulate the body’s first line of defense against air-borne diseases. Through the process of photo-oxidation, the melanin and superoxide dismutase (SOD) in skin produces hydrogen peroxide when exposed to UV-Aid light. Hydrogen peroxide is a known safe and effective antiviral agent. Once the hydrogen peroxide has performed its task of killing germs, the body breaks it down into harmless products of water and oxygen.

Quoting Mr. McGuire, "With our model we have accurately predicted when a killer has run its course, and building on our model we have developed a promising new technology to help prevent future pandemics."

About UV Technologies, LLC:

UV Technologies, LLC’s mission is to provide the best and most innovative products for customers’ health and well-being using safe and natural modalities. UV-Aid helps prevent colds, flu, sore throats, sinus, and ear infections through the natural process of photo-oxidation. UV Technologies is an accredited business member of the Better Business Bureau. Visit http://www.uvaid.com for more information.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10752345.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Systems Technologies Now Provides Compatibility with Discontinued Inovonics FA Wireless Equipment
2. omNovia Technologies to Exhibit at Streaming Media East
3. Epicor Customer Conference 2013 in Nashville Spotlights the Latest Technologies to Drive Performance and Productivity, Including doc-link by Altec
4. Citel Technologies, Inc. Announces Firmware Release 6.01.0 for its Portico™ TVA™
5. Sensors Technologies Market (Image, Pressure, Flow & Level) Analysis in New Research Report at ReportsnReports.com
6. UV Technologies, Makers of UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in Northern Hemisphere as Available Daylight Increases
7. DeepWell Archival Services Announces Partnership with Keystone Medical Technologies
8. LP Accessible Technologies Helping the Valley, One LP Pad at a Time
9. Internet Marketing Company SBR Technologies Pvt Ltd Wins ISO 9001: 2008 Certification
10. Alliance Storage Technologies and Blue Chip Technical Services (Pvt) Ltd. Announce Partnership to Expand the Reach of Professional Data Archiving Solutions
11. iDCLOAK Technologies Releases a Proxy Servers List Designed Specifically for Web Censorship Circumvention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: